Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IQuest Enterprises entered into a definitive agreement to acquire Viatris’ API operations in India, including six manufacturing facilities and an R&D center. The deal is the largest pharmaceutical investment for IQuest, enabling it to become a major Indian API manufacturer and supplier. Clinical results are not directly relevant as it is a manufacturer, not a developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IQuest Enterprises.